Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case reportJoseph F. Arboleda‐Velásquez, Yakeel T. Quiroz, Francisco Lopera et al.|Nature Medicine|2019Cited by 606
Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control studyEric M. Reiman, Francisco Lopera, Yakeel T. Quiroz et al.|The Lancet Neurology|2012Cited by 553
Symptom onset in autosomal dominant Alzheimer diseaseDavis C. Ryman, Eric McDade, Sonia Moreno et al.|Neurology|2014Cited by 515
Consortium to Establish a Registry for Alzheimer's Disease (CERAD): The first twenty yearsGerda G. Fillenbaum, Albert Heyman, Gerald van Belle et al.|Alzheimer s & Dementia|2008Cited by 491
A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer diseaseStephen Salloway, Reisa A. Sperling, Ron Keren et al.|Neurology|2011Cited by 255